Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2012
08/30/2012WO2012115177A1 N-[(biaryloxy)alkylcarbonyl]sulfonamide derivative
08/30/2012WO2012115176A1 3-(biaryloxy)propionic acid derivative
08/30/2012WO2012115064A1 Ppar activator
08/30/2012WO2012113564A1 Stabilized granules containing glyceryl trinitrate
08/30/2012WO2012113563A1 Packaging of solid pharmaceutical preparations containing the active substance glyceryl trinitrate
08/30/2012WO2012113103A1 Asymmetric ureas and medical uses thereof
08/30/2012WO2012057492A3 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein a-i and a mutant thereof
08/30/2012US20120222142 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
08/30/2012US20120220759 Synthetic heparin disaccharides
08/30/2012US20120220666 Composition to enhance the bioavailability of curcumin
08/30/2012US20120220663 Solid forms of aliskiren hemifumarate and processes for preparation thereof
08/30/2012US20120220657 Synergistic anti-inflammatory and antioxidant dietary supplement compositions
08/30/2012US20120220656 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease
08/30/2012US20120220643 Amino Acid Compounds
08/30/2012US20120220642 Amino Acid Compounds
08/30/2012US20120220641 Laser enhanced amino acid blend and use of same to regenerate active myocardial tissue
08/30/2012US20120220631 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR
08/30/2012US20120220629 Asymmetric ureas and medical uses thereof
08/30/2012US20120220626 Novel quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease
08/30/2012US20120220611 1,3-benzoxazolyl derivatives as kinase inhibitors
08/30/2012US20120220606 New capped pyrazinoylguanidine sodium channel blockers
08/30/2012US20120220592 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
08/30/2012US20120220591 Pyrimidone compounds
08/30/2012US20120220588 Quinazoline compounds
08/30/2012US20120220587 Pyridinylimidazolone derivatives for the inhibition of pi3 kinases
08/30/2012US20120220575 N-substituted oxazinopteridines and oxazinopteridinones
08/30/2012US20120220568 Histamine-3 Receptor Antagonists
08/30/2012US20120220567 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
08/30/2012US20120220563 Substituted piperidines
08/30/2012US20120220561 Oxadiazole inhibitors of leukotriene production
08/30/2012US20120220559 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/30/2012US20120220556 Drospirenone for hormone replacement therapy
08/30/2012US20120220543 Treatment of Glaucoma and Other Retinopathies with Gangliosides
08/30/2012US20120220535 Cyclic-glur6 analogs, methods of treatment and use
08/30/2012US20120220532 Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
08/30/2012US20120220529 Nitric oxide-blocked cross-linked tetrameric hemoglobin
08/30/2012US20120220528 Systems and methods for therapy of kidney disease and/or heart failure using chimeric natriuretic peptides
08/30/2012US20120220525 Stablized Melanocortin Ligands
08/30/2012US20120219639 Nutritional supplement for patients with chronic heart failure
08/30/2012US20120219629 Compositions and methods for controlled delivery of compounds
08/30/2012US20120219623 Pharmaceutical compositions comprising bi-1356 and metformin
08/30/2012US20120219621 Composition with Enhanced Thermogenic Activity and the Use Thereof in the Prevention and Treatment of Obesity
08/30/2012US20120219619 Substances for reducing occurrence of major cardiac events in humans
08/30/2012US20120219611 Hypotensive lipid-containing biodegradable intraocular implants and related methods
08/30/2012US20120219598 Polymeric micelles for reducing ldl in vivo
08/30/2012US20120219596 Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
08/30/2012US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
08/30/2012US20120219567 Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
08/30/2012US20120219510 Natural extract from whole banana fruit (musa spp)
08/30/2012US20120219498 Compositions and methods for inducing angiogenesis
08/30/2012US20120219495 Novel tetraaza macrocyclic compound, preparation method thereof and use thereof
08/30/2012US20120216801 Treprostinil administration by inhalation
08/30/2012CA2827716A1 Stabilized granules containing glyceryl trinitrate
08/30/2012CA2827714A1 Packaging of solid pharmaceutical preparations containing the active substance glyceryl trinitrate
08/29/2012EP2492269A1 Aminothiazole derivative
08/29/2012EP2492262A1 Fused heterocyclic compound and thrombopoietin receptor activator
08/29/2012EP2491942A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
08/29/2012EP2491941A1 Organ preservation and/or perfusion
08/29/2012EP2491036A2 Pyrazolopyrimidine derivatives
08/29/2012EP2491022A1 Diazepam derivatives as modulators of chemokine receptors
08/29/2012EP2491005A1 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease
08/29/2012EP2490702A1 Treatment using reprogrammed mature adult cells
08/29/2012EP2490701A2 Cardiomyocyte production
08/29/2012EP2490694A2 Methods and systems for pharmacogenomic treatment of cardiovascular conditions
08/29/2012EP2490686A1 The new application of 2-pyrrolidone derivatives
08/29/2012EP2490678A1 Coated capsules and tablets of a fatty acid oil mixture
08/29/2012EP2008664B1 Modified proteins which bind extracellular matrix components
08/29/2012CN1948275B Verakanol Mannich alkali derivative, its preparation method and use
08/29/2012CN1841066B Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/29/2012CN1636594B Angiostatin and use of the same for inhibition of angiogenesis
08/29/2012CN102649787A (benzimidazole-2-yl)pyridine derivative and application thereof to preparation of anticoagulant medicines
08/29/2012CN102648974A Chinese medicine formulation for treating heart diseases
08/29/2012CN102648965A Industrialization preparation method of lophatherum gracile general flavone
08/29/2012CN102648964A Medicine for treating headache, hypertension and cardiovascular and cerebrovascular disease
08/29/2012CN102648961A Medicine for treating ischemic stroke sequela
08/29/2012CN102648960A Traditional Chinese medicine pill and preparation method thereof
08/29/2012CN102648946A Warm compression thermal therapy liquid and preparation method thereof
08/29/2012CN102648943A Preparation method of heart soothing preparation
08/29/2012CN102648941A New application for antioxidation action of cortex dictamni extract
08/29/2012CN102648939A Preparation method for geum aleppicum polyphenol
08/29/2012CN102648932A Method for extracting alfalfa saponin
08/29/2012CN102648925A Preparation method of achyranthes bidentata saponin
08/29/2012CN102648916A Treprostinil treatment for interstitial lung disease and asthma
08/29/2012CN102648903A Preparation method for beta-cyclodextrin inclusion compound of beta-carotene
08/29/2012CN102266447B Chinese medicinal composition for treating coronary heart disease
08/29/2012CN102266333B Brand new medicinal composition containing levamlodipine and atorvastatin calcium and preparation method thereof
08/29/2012CN102266332B Brand new medicinal composition containing levamlodipine besylate and telmisartan and preparation method thereof
08/29/2012CN102258709B Traditional Chinese medicine preparation for treating diabetic retinopathy, and preparation method thereof
08/29/2012CN102258702B Medicine for treating hypertension
08/29/2012CN102228658B Medicament for treating arteriosclerotic cerebral infarction and preparation method thereof
08/29/2012CN102125608B Traditional Chinese medicine preparation for treating hypertension of liver-yang hyperactivity type
08/29/2012CN102125590B Ginsenoside Rg1-containing pseudo-ginseng active ingredient as well as preparation method and application thereof
08/29/2012CN102099026B Therapeutic compositions containing macitentan
08/29/2012CN102058579B Application of dehydrocostuslactone to preparing drug for inhibiting angiogenesis
08/29/2012CN102038721B Pinus extract and application thereof
08/29/2012CN102008464B Application of levobutyl phthalide in preparation of medicament for preventing and treating cerebral infarction
08/29/2012CN101961447B Novel preparation method, preparation and application of Chinese medicinal composition
08/29/2012CN101912566B Traditional Chinese medicine for treating palpitation
1 ... 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 ... 1595